Study highlights risks of stopping anticoagulants in older patients

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.

Dr. Reddy’s and Stanford spinout Kainomyx partner up on anti-malarial program

Dr. Reddy’s Laboratories, its CRDMO arm Aurigene and Stanford spinout Kainomyx are teaming up to develop an anti-malarial drug with a new mechanism of action

August 22, 2024

Homeless women experience practical challenges in managing menstruation alongside feelings of embarrassment and shame

A new study published online in Women and Health reviews literature on this topic, from the practical challenges through the emotional strain to demonstrations of

March 19, 2024

IMS-001 by Imstem Biotechnology for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.